Table 3 Clinical profiles of participants by HBsAg positivity and awareness of serostatus
HBsAg(−) | HBsAg(+) | uaHB | aHB | |
|---|---|---|---|---|
Number | 3039 | 454 | 179 | 275 |
BMI < 24 kg/m2 (%) | 1354(44.6) | 204(45.3) | 74(42.0) | 130(47.4) |
BMI > 24, <27 kg/m2 (%) | 867(28.6) | 141(31.3) | 51(29.0) | 90(32.8) |
BMI ≥ 27 kg/m2 (%) | 812(26.8) | 105(23.3) | 51(25.0) | 54(19.7) |
Metabolic syndrome (%) | 968(31.9) | 135(29.7) | 72(40.2) | 63(22.9) |
Elevated blood pressure (%) | 1756(57.8) | 262(57.7) | 115(64.2) | 147(53.5) |
Central obesity (%) | 1238(40.7) | 175(38.5) | 94(52.5) | 81(29.5) |
Hypertriglyceridemia (%) | 797(26.2) | 86(18.9) | 42(23.5) | 44(16.0) |
Low HDL-C (%) | 660(21.7) | 98(21.6) | 45(25.1) | 53(19.3) |
Hyperglycemia (%) | 1220(40.1) | 161(35.5) | 82(45.8) | 79(28.7) |
Total cholesterol ≥ 200 mg/dL (%) | 1790(58.9) | 247(54.4) | 95(53.1) | 152(55.3) |
LDL-C ≥ 130 mg/dL (%) | 1305(42.9) | 185(40.7) | 71(39.7) | 114(41.5) |
HOMA-IR ≥ 1.9 (%) | 1124(37.0) | 188(41.4) | 95(53.1) | 93(33.8) |
Fatty liver (%) | 532/910(58.5) | 82(52.6) | 27/49(55.1) | 55/107(51.4) |
APRI > 0.5 (%) | 220(7.2) | 63(13.9) | 28(15.6) | 35(12.7) |
APRI > 1.0 (%) | 25(0.8) | 8(1.8) | 5(2.8) | 3(1.1) |
